Prospective randomised controlled trial comparing 1% and 2% lignocaine as a form of anaesthesia prior to prostate biopsy
| ISRCTN | ISRCTN43667535 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN43667535 |
| Secondary identifying numbers | N0059132320 |
- Submission date
- 30/09/2004
- Registration date
- 30/09/2004
- Last edited
- 12/02/2018
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English Summary
Not provided at time of registration
Contact information
Mr Santbir Mehta
Scientific
Scientific
University of Sheffield
Urology
Royal Hallamshire Hospital
Sheffield
S26 4SY
United Kingdom
| Phone | +44 (0)788 956 9670/271 2154 |
|---|---|
| sampimehta@aol.com |
Study information
| Study design | Randomised controlled trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Hospital |
| Study type | Other |
| Participant information sheet | Not available in web format, please use the contact details to request a patient information sheet |
| Scientific title | Prospective randomised controlled trial comparing 1% and 2% lignocaine as a form of anaesthesia prior to prostate biopsy |
| Study hypothesis | To identify any difference in relief of discomfort of prostate biopsy when using 1% or 2% lignocaine periprostatic nerve block |
| Ethics approval(s) | Not provided at time of registration |
| Condition | Prostate cancer |
| Intervention | Prospective randomised controlled trial comparing 1% and 2% lignocaine as a form of anaesthesia prior to prostate biopsy |
| Intervention type | Drug |
| Pharmaceutical study type(s) | |
| Phase | Not Applicable |
| Drug / device / biological / vaccine name(s) | Lignocaine |
| Primary outcome measure | Difference on visual analogue scale (VAS) |
| Secondary outcome measures | Not provided at time of registration |
| Overall study start date | 01/01/2004 |
| Overall study end date | 30/04/2004 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | Male |
| Target number of participants | Not provided at time of registration |
| Participant inclusion criteria | CaP (prostate cancer) patients |
| Participant exclusion criteria | Does not match inclusion criteria |
| Recruitment start date | 01/01/2004 |
| Recruitment end date | 30/04/2004 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
University of Sheffield
Sheffield
S26 4SY
United Kingdom
S26 4SY
United Kingdom
Sponsor information
Department of Health
Government
Government
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
| Website | http://www.dh.gov.uk/Home/fs/en |
|---|
Funders
Funder type
Hospital/treatment centre
Sheffield Teaching Hospitals NHS Foundation Trust (UK)
No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
Editorial Notes
12/02/2018: No publications found, verifying study status with principal investigator.
